A— AGILENT TECHNOLOGIES, INC.

Health CareLife Sciences Tools & Services$41.2B mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net revenue	$2.00B+9.0%	$1.84B+3.1%	$1.78B+7.3%	$1.66B
Cost of revenue	$1.07B+12.3%	$951.0M+1.2%	$940.0M+6.3%	$884.0M
Research and development	$455.0M-5.0%	$479.0M-0.4%	$481.0M+3.0%	$467.0M
Selling, general and administrative	$1.71B+9.0%	$1.57B-4.0%	$1.63B-0.2%	$1.64B
Total costs and expenses	$5.47B+8.9%	$5.02B-8.4%	$5.48B+4.8%	$5.23B
Income from operations	$1.48B-0.6%	$1.49B+10.2%	$1.35B-16.6%	$1.62B
Interest income	$62.0M-22.5%	$80.0M+56.9%	$51.0M+466.7%	$9.0M
Interest expense	-$112.0M-16.7%	-$96.0M-1.1%	-$95.0M-13.1%	-$84.0M
Other income (expense), net	$6.0M-87.8%	$49.0M+48.5%	$33.0M+184.6%	-$39.0M
Income before taxes, as reported	$1.44B-5.7%	$1.52B+13.6%	$1.34B-11.0%	$1.50B
Provision for income taxes	$132.0M-43.1%	$232.0M+134.3%	$99.0M-60.4%	$250.0M
Net Income	$1.30B+1.1%	$1.29B+4.0%	$1.24B-1.1%	$1.25B
Net income per share - basic	$4590000.00+3.4%	$4440000.00+5.2%	$4220000.00+0.7%	$4190000.00
Net income per share - diluted	$4570000.00+3.2%	$4430000.00+5.7%	$4190000.00+0.2%	$4180000.00
Basic (in shares)	284.0M-2.1%	290.0M-1.4%	294.0M-1.7%	299.0M
Diluted (in shares)	285.0M-2.1%	291.0M-1.7%	296.0M-1.3%	300.0M
Products
Services and Other

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 13 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.